MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Aptose Biosciences Company Profile (NASDAQ:APTO)

Consensus Ratings for Aptose Biosciences (NASDAQ:APTO) (?)
Ratings Breakdown: 1 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $13.00 (383.27% upside)

Analysts' Ratings History for Aptose Biosciences (NASDAQ:APTO)
Show:
DateFirmActionRatingPrice TargetActions
3/30/2016Canaccord GenuityReiterated RatingBuy$13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/30/2016RBC CapitalLower Price TargetOutperform$19.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/23/2015OppenheimerReiterated RatingOutperform$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/20/2015Roth CapitalDowngradeBuy -> Neutral$20.00 -> $4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/24/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha